Oncomine Tumor-Specific Panels

Focused cancer research

A one-size-fits-all approach just doesn’t work for everyone, so we’ve developed a range of Oncomine assays to cover the spectrum of panel sizes and purposes.

Choose Oncomine tumor-specific panels

Ion Torrent Oncomine tumor-specific panels complement Oncomine assays, providing end-to-end solutions for researching the molecular profile of specific tumors from formalin-fixed paraffin-embedded (FFPE) tissue samples.

Search genes Download flyer

These dynamic panels are created from a curated inventory of pre-tested genes relevant to cancer research and sized to be economical (15–30 genes).

Available via ampliseq.com and manufactured on demand
Low sample input requirement and robust performance on FFPE tissue
End-to-end research workflow, including bioinformatics and a reporting solution
Specialized support for assay verification

Oncomine tumor-specific panels for cancer research

Oncomine Bladder Panel

25-gene panel applicable to urothelial carcinoma (~90% of bladder cancers). Contains genes such as PIK3CA, FGFR3, and ERBB2.

Oncomine Kidney Panel

15-gene panel applicable to renal cell carcinomas (the majority of kidney cancers). Contains genes such as VHL, MTOR, and PBRM1

Oncomine BRCA Expanded Panel

15-gene panel containing BRCA1 and BRCA2 as well as HR pathway genes important for ovarian, breast, and prostate cancer research. Contains genes such as ATM, PALB2, and BRIP1.

Oncomine Liver Panel

22-gene panel applicable to hepatocellular carcinoma (HCC) and intrahepatic cholangiocarcinoma (ICC). Contains genes such as TP53, MYC, TERT, and CTNNB1.

Oncomine Colorectal and Pancreatic Panel

24-gene panel applicable to colorectal and pancreatic adenocarcinoma, including DNA mismatch repair pathway genes. Also contains genes such as APC, KRAS, and NRAS.

Oncomine Lymphoma Panel

25-gene panel applicable to non-Hodgkin’s lymphomas (primarily diffuse large B cell (DLBCL)) as well as to Hodgkin’s lymphoma. Contains genes such as BCL2, MYD88, and CARD11.